1. Prevymis is an antiviral drug used to prevent cytomegalovirus infections in patients after a stem cell transplant.
2. Vyzulta is a once-daily treatment to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
3. Zelboraf is the first approved treatment for Erdheim-Chester disease, a rare form of blood cancer.
4. Alecensa may now be used as an initial treatment for patients with a rare form of non-small-cell lung cancer.
More articles on supply chain:
6 medical groups to Congress: We need a ‘comprehensive strategy’ for critical drug shortages
AHA urges FDA to address saline bag shortage
5 recent pharma layoffs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
